Home
About
Science
Pipeline
Career
Media
Contact
More
Our Pipeline
Our pipeline assets range from a cell therapy targeting the root cause of many autoimmune diseases, to a monoclonal antibody for a new immuno-oncology target, and to a clinical diagnostic assay.